Article
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral hepatitis B.
World journal of gastroenterology - 1 Oct 2002
Yang Sien-Sing, Hsu Chao-Tien, Hu Jui-Ting, Lai Yung-Chih, Wu Chi-Hwa
Abstract excerpt
AIM: To study the role of lamivudine in improving the efficiency of interferon for the treatment of mutant type chronic hepatitis B. METHODS: Fifteen patients with mutant type chronic hepatitis B were prospectively studied. All patients had liver histology and serology to prove the diagnosis of chronic hepatitis B. Each patient received 4.5 million units of interferon alpha-2a thrice weekly and 100 mg of oral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
